Thalidomide: lack of mutagenic activity across phyla and genetic endpoints-Reference-Cited by-同舟云学术

Thalidomide: lack of mutagenic activity across phyla and genetic endpoints

Published:1997-12 Issue:1-2 Volume:396 Page:45-64
ISSN:0027-5107
Container-title:Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis
language:en
Short-container-title:Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis

Author:

Ashby J.,Tinwell H.,Callander R.D.,Kimber I.,Clay P.,Galloway S.M.,Hill R.B.,Greenwood S.K.,Gaulden M.E.,Ferguson M.J.,Vogel E.,Nivard M.,Parry J.M.,Williamson J.

Publisher

Elsevier BV

Subject

Health, Toxicology and Mutagenesis,Genetics,Molecular Biology

Reference59 articles.

1. Thalidomide may be a mutagen;McBride;British Medical Journal,1994

2. Thalidomide and congenital abnormalities;McBride;Lancet,1961

3. Distaval;Hayman;Lancet,1961

4. Thalidomide and congenital abnormalities;Kemper;Lancet,1962

5. Chromosomes of thalidomide-deformed foetuses;Hughes;Lancet,1962

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Congenital Single Digit Deformities: Series of Cases in Multiple Families in Remote Villages of Haryana;Journal of Surgical Specialties and Rural Practice;2024-05

2. EVOLVING KNOWLEDGE IN FRAMING OF TERATOGENIC ACTIVITY TOWARDS RISK PERCEPTION;INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH;2020-08-01

3. A clinical review and introduction of the diagnostic algorithm for thalidomide embryopathy (DATE);Journal of Hand Surgery (European Volume);2018-09-25

4. The utility of metabolic activation mixtures containing human hepatic post-mitochondrial supernatant (S9) forin vitrogenetic toxicity assessment;Mutagenesis;2015-12-27

5. Thalidomide‐induced teratogenesis: History and mechanisms;Birth Defects Research Part C: Embryo Today: Reviews;2015-06